Atlas Global Brands Inc
CNSX:ATL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (11.4), the stock would be worth CA$-1.53 (1 120% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -1.1 | CA$0.15 |
0%
|
| Industry Average | 11.4 | CA$-1.53 |
-1 120%
|
| Country Average | 14.5 | CA$-1.95 |
-1 399%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
A
|
Atlas Global Brands Inc
CNSX:ATL
|
23.8m CAD | -1.1 | -1.5 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
303.9B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 3 537.2 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
102.5B ZAR | 14.4 | 10.6 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68B USD | -17 989.5 | 38 417.9 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
61.5B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.4B CHF | 0 | 0 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
38.1B USD | -746.3 | -3 496.9 | |
| US |
|
Coupang Inc
F:788
|
31.7B EUR | 67.3 | 175.5 | |
| US |
R
|
Reddit Inc
NYSE:RDDT
|
31.4B USD | 62.7 | 57 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10.6 |
| Median | 14.5 |
| 70th Percentile | 20.6 |
| Max | 3 794.4 |
Other Multiples
Atlas Global Brands Inc
Glance View
Atlas Global Brands, Inc. engages in the medical cannabis value chain, which includes cultivation, manufacture, marketing, distribution, and pharmacy. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2009-04-08. The firm is engaged in cannabis value chain business, which includes cultivation, manufacturing, scalability, marketing, distribution, and pharmacy. The firm serves across eight countries, which include Australia, Canada, Denmark, Germany, Israel, Norway, Spain, and the United Kingdom. The company also operates two fully accredited and licensed cannabis facilities, including one European Union-Goods Manufacturing Practices (EU-GMP) facility. The firm primarily operates in Canada and Israel.
